Using Patient Reported Outcome measures (PROs) to promote quality of care and safety in the management of patients with end stage renal disease (ESRD) requiring treatment with haemodialysis

被引：0
|
作者：
Anderson, Nicola E. [1 ]
Calvert, Melanie J. [2 ]
Cockwell, Paul [3 ]
Dutton, Mary [4 ]
Kyte, Derek G. [2 ]
机构：
[1] Univ Birmingham, Birmingham, W Midlands, England
[2] Ctr Patient Reported Outcomes Res, Birmingham, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[4] Univ Hosp NHS Fdn Trust, Birmingham, W Midlands, England
来源：
QUALITY OF LIFE RESEARCH | 2017年 / 26卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
3083
引用
收藏
页码：128 / 128
页数：1
相关论文
共 36 条
  • [31] Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes
    Laura C Plantinga
    Rachel E Patzer
    Cristina Drenkard
    Stephen O Pastan
    Jason Cobb
    William McClellan
    Sung Sam Lim
    BMC Nephrology, 16
  • [32] The impact of patient safety incidents during hip and knee replacements on patients' health related quality of life: a before and after study using longitudinal data linked to patient-reported outcome measures
    Xiao, Mimi
    Kristensen, Sren Rud
    Marti, Joachim
    Mossialos, Elias
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (05) : 1085 - 1093
  • [33] Phase 1 /1 b Pharmacokinetic (PK) and Safety Study of the Investigational Oral Proteasome Inhibitor (PI) Ixazomib in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) with Severe Renal Impairment or End-Stage Renal Disease (ESRD) Requiring Hemodialysis
    Gupta, Neeraj
    Hanley, Michael J.
    Harvey, R. Donald
    Badros, Ashraf Z.
    Lipe, Brea C.
    Kukreti, Vishal
    Berdeja, Jesus G.
    Yang, Huyuan
    Hui, Al-Min
    Zhang, Xiaoquan
    VenkatakrishnanPhd, Karthik
    Chari, Ajai
    BLOOD, 2015, 126 (23)
  • [34] Successful treatment of bortezomib-refractory multiple myeloma derived from monoclonal gammopathy of undetermined significance with dose-adjusted lenalidomide therapy in a patient with concomitant end-stage renal disease due to diabetic nephropathy requiring haemodialysis
    Noriaki Kawano
    Naoko Yokota-Ikeda
    Kunihiro Minoda
    Hiroshi Hashiguchi
    Shuro Yoshida
    Takuro Kuriyama
    Kiyoshi Yamashita
    Yoshimasa Miyazaki
    Sanshiro Inoue
    Yoshiya Shimao
    Keiko Kodama
    Shigehiro Uezono
    Akira Ueda
    CEN Case Reports, 2014, 3 (1) : 24 - 29
  • [35] Successful treatment of bortezomib-refractory multiple myeloma derived from monoclonal gammopathy of undetermined significance with dose-adjusted lenalidomide therapy in a patient with concomitant end-stage renal disease due to diabetic nephropathy requiring haemodialysis
    Kawano, Noriaki
    Yokota-Ikeda, Naoko
    Minoda, Kunihiro
    Hashiguchi, Hiroshi
    Yoshida, Shuro
    Kuriyama, Takuro
    Yamashita, Kiyoshi
    Miyazaki, Yoshimasa
    Inoue, Sanshiro
    Shimao, Yoshiya
    Kodama, Keiko
    Uezono, Shigehiro
    Ueda, Akira
    CEN CASE REPORTS, 2014, 3 (01): : 24 - 29
  • [36] Electronic patient-reported outcome (e-PRO) monitoring for adverse event management during cabozantinib treatment in patients with advanced renal cell carcinoma: protocol for a three-arm, randomised, multicentre phase II trial (e-PRO vs paper-PRO or usual care)
    Osawa, Takahiro
    Fujii, Yasuhisa
    Kimura, Go
    Kitamura, Hiroshi
    Nagashima, Yoji
    Iizumi, Sakura
    Osaka, Tsuyoshi
    Tsubouchi, Ryoichi
    Shinohara, Nobuo
    BMJ OPEN, 2023, 13 (07):
1234